News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
794,970 Results
Type
Article (79064)
Company Profile (291)
Press Release (715615)
Multimedia
Podcasts (117)
Webinars (14)
Section
Business (217054)
Career Advice (3527)
Deals (38123)
Drug Delivery (127)
Drug Development (89519)
Employer Resources (186)
FDA (17843)
Job Trends (16559)
News (374937)
Policy (37491)
Tag
Academia (2991)
Academic (2)
Accelerated approval (6)
Adcomms (29)
Allergies (94)
Alliances (55033)
ALS (99)
Alzheimer's disease (1501)
Antibody-drug conjugate (ADC) (156)
Approvals (17811)
Artificial intelligence (300)
Autoimmune disease (27)
Automation (16)
Bankruptcy (377)
Best Places to Work (12469)
BIOSECURE Act (21)
Biosimilars (119)
Biotechnology (198)
Bladder cancer (84)
Brain cancer (32)
Breast cancer (303)
Cancer (2425)
Cardiovascular disease (202)
Career advice (2995)
Career pathing (34)
CAR-T (171)
Cell therapy (483)
Cervical cancer (21)
Clinical research (72252)
Collaboration (909)
Compensation (503)
Complete response letters (30)
COVID-19 (2852)
CRISPR (47)
C-suite (264)
Cystic fibrosis (107)
Data (2257)
Decentralized trials (2)
Denatured (44)
Depression (55)
Diabetes (295)
Diagnostics (6847)
Digital health (20)
Diversity (9)
Diversity, equity & inclusion (44)
Drug discovery (138)
Drug pricing (124)
Drug shortages (32)
Duchenne muscular dystrophy (101)
Earnings (85486)
Editorial (44)
Employer branding (23)
Employer resources (160)
Events (121617)
Executive appointments (772)
FDA (19156)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (810)
Gene editing (118)
Generative AI (31)
Gene therapy (353)
GLP-1 (837)
Government (5097)
Grass and pollen (6)
Guidances (59)
Healthcare (20612)
Huntington's disease (25)
IgA nephropathy (31)
Immunology and inflammation (146)
Indications (30)
Infectious disease (3010)
Inflammatory bowel disease (151)
Inflation Reduction Act (11)
Influenza (57)
Intellectual property (101)
Interviews (670)
IPO (17346)
IRA (48)
Job creations (4542)
Job search strategy (2479)
Kidney cancer (11)
Labor market (36)
Layoffs (546)
Leadership (24)
Legal (9099)
Liver cancer (81)
Lung cancer (345)
Lymphoma (158)
Machine learning (7)
Management (65)
Manufacturing (338)
MASH (73)
Medical device (14324)
Medtech (14329)
Mergers & acquisitions (21342)
Metabolic disorders (772)
Multiple sclerosis (87)
NASH (23)
Neurodegenerative disease (113)
Neuropsychiatric disorders (33)
Neuroscience (2102)
NextGen: Class of 2025 (7375)
Non-profit (5058)
Now hiring (30)
Obesity (411)
Opinion (275)
Ovarian cancer (78)
Pain (97)
Pancreatic cancer (86)
Parkinson's disease (161)
Partnered (23)
Patents (248)
Patient recruitment (114)
Peanut (51)
People (63577)
Pharmaceutical (65)
Pharmacy benefit managers (21)
Phase I (22298)
Phase II (31441)
Phase III (23672)
Pipeline (1234)
Policy (163)
Postmarket research (3397)
Preclinical (10008)
Press Release (71)
Prostate cancer (113)
Psychedelics (38)
Radiopharmaceuticals (269)
Rare diseases (429)
Real estate (6920)
Recruiting (73)
Regulatory (25590)
Reports (45)
Research institute (2643)
Resumes & cover letters (550)
Rett syndrome (5)
RNA editing (5)
RSV (48)
Schizophrenia (80)
Series A (142)
Series B (91)
Service/supplier (18)
Sickle cell disease (58)
Special edition (18)
Spinal muscular atrophy (164)
Sponsored (34)
Startups (3938)
State (2)
Stomach cancer (16)
Supply chain (73)
Tariffs (41)
The Weekly (71)
Vaccines (802)
Venture capitalists (43)
Weight loss (293)
Women's health (40)
Worklife (20)
Date
Today (181)
Last 7 days (915)
Last 30 days (2802)
Last 365 days (34750)
2025 (11385)
2024 (37141)
2023 (42001)
2022 (53298)
2021 (58163)
2020 (57157)
2019 (50809)
2018 (38701)
2017 (36054)
2016 (36420)
2015 (42560)
2014 (36805)
2013 (33295)
2012 (34904)
2011 (34939)
2010 (34738)
Location
Africa (1150)
Alabama (59)
Alaska (7)
Arizona (237)
Arkansas (14)
Asia (47253)
Australia (8295)
California (6239)
Canada (2040)
China (558)
Colorado (277)
Connecticut (294)
Delaware (151)
Europe (109092)
Florida (923)
Georgia (217)
Idaho (62)
Illinois (612)
India (29)
Indiana (318)
Iowa (10)
Japan (168)
Kansas (108)
Kentucky (25)
Louisiana (12)
Maine (70)
Maryland (928)
Massachusetts (4748)
Michigan (235)
Minnesota (409)
Mississippi (2)
Missouri (91)
Montana (31)
Nebraska (25)
Nevada (65)
New Hampshire (70)
New Jersey (1795)
New Mexico (31)
New York (1799)
North Carolina (1082)
North Dakota (9)
Northern California (2688)
Ohio (215)
Oklahoma (15)
Oregon (38)
Pennsylvania (1372)
Puerto Rico (13)
Rhode Island (33)
South America (1509)
South Carolina (23)
South Dakota (1)
Southern California (2351)
Tennessee (103)
Texas (935)
United States (23991)
Utah (190)
Virginia (160)
Washington D.C. (69)
Washington State (575)
West Virginia (3)
Wisconsin (63)
794,970 Results for "european organization for research and treatment of cancer".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
European Commission approves subcutaneous RYBREVANT®▼ (amivantamab) for the treatment of patients with advanced EGFR-mutated non-small cell lung cancer
April 8, 2025
·
17 min read
Press Releases
Biodesix partner, Friends of Cancer Research, publishes data in Clinical Cancer Research, demonstrating strong association between ctDNA changes and treatment outcomes for patients with solid tumor types
April 23, 2025
·
5 min read
Press Releases
Lynozyfic™ (linvoseltamab) Approved in the European Union for the Treatment of Relapsed/Refractory Multiple Myeloma
April 29, 2025
·
14 min read
Press Releases
Glucotrack to Participate in FORGETDIABETES, a Prominent European Research Initiative to Develop a Bionic Pancreas
April 16, 2025
·
5 min read
Press Releases
Greater Precision of HER2-Expressing Breast Cancer Treatment with 3D Pathology: New JelloX Research Collaboration
April 17, 2025
·
3 min read
Press Releases
ORIC® Pharmaceuticals Presents Preclinical Data to Support the Potential of ORIC-944 as a Best-in-Class PRC2 Inhibitor for the Treatment of Prostate Cancer at the 2025 American Association for Cancer Research (AACR) Annual Meeting
April 28, 2025
·
6 min read
Press Releases
New Research in JNCCN Finds Stark Disparities in Treatment and Survival Time for People with Pancreatic Cancer
April 10, 2025
·
5 min read
Press Releases
Izotropic Featured in Announcement of Research and Markets’ U.S. Breast Cancer Analysis and Forecast
- Company listed in Research and Markets’ announcement and description of new research report on the U.S. Breast Cancer Screening and Diagnostic Market- - “U.S. breast cancer screening and diagnostic [device] market was valued at $1.55 billion in 2024 and is anticipated to reach $2.34 billion by the end of 2030, at a CAGR of 7.05% during the forecast period 2024-20301"- -Report supports Company’s regulatory strategy for IzoView Breast CT, reinforces high demand for new breast imaging modalities, strengthens the potential for rapid market adoption and significant market share -
January 17, 2025
·
8 min read
Press Releases
Innovative Startups Developing Next-Gen Cancer Treatments and Radiation-Shielding Material Selected Through MassChallenge Accelerator for Space-Based Research
April 11, 2025
·
5 min read
News
HyBryte™ Expanded Treatment Results to be Presented at the European Organisation for Research and Treatment of Cancer Conference
October 7, 2024
·
15 min read
1 of 79,497
Next
